Exploring the Future of Intradermal Delivery with NanoPass Technologies
NanoPass Technologies Ltd., recognized as a leader in the field of intradermal delivery solutions, is making waves with the upcoming launch of their latest product, the MicronJet™ 800. Set to debut at IMCAS World 2026 in Paris from January 29 to 31, this innovative device aims to broaden the MicronJet™ family, which already includes the successful MicronJet™ 600.
A New Era in Aesthetic Solutions
The MicronJet™ 800 introduces significant advancements tailored for applications in hair restoration and treatment of thicker skin areas. With a thickness of 0.8 mm, the device is designed to deliver effective and pain-free injections to the scalp, an essential area for non-surgical hair restoration. Its ability to control penetration depth ensures that practitioners can achieve consistent results, which is vital for various aesthetic and dermatological treatments including jawline enhancements, hyperhidrosis, and scar revisions.
Enhanced Performance
Uniquely, the MicronJet™ 800 achieves a flow rate equivalent to a 27-gauge needle while ensuring precise intradermal delivery. It caters specifically to medium-to-high viscosity formulations, enabling it to easily handle thicker substances that require accurate depth and placement. Compatible with standard Luer-lock or Luer-slip syringes of less than 3 mL, practitioners can seamlessly incorporate the device into their procedures after a brief training session.
The Technology Behind MicronJet™
What sets the MicronJet™ devices apart from traditional stainless-steel needles is their synthesis with pure silicon-crystal delivery pyramids via semiconductor-grade MEMS technology. This distinctive construction not only enhances durability and reliability during injection but also reduces the likelihood of discomfort for patients during multiple injections. Currently, the MicronJet™ technology is backed by over 70 clinical studies that encompass diverse domains such as vaccine administration, allergy testing, immunotherapy, and various aesthetic applications, confirming its reliability across different uses.
Voices From the Field
Dr. Alberto Diaspro, a renowned Maxillofacial Plastic Surgeon from Italy, highlights the paramount benefits of the MicronJet™ in scalp therapy, emphasizing that its virtually pain-free experience makes it advantageous for both patients and healthcare providers. He states, “MicronJet™ ensures effective intradermal placement while maintaining comfort, establishing it as the ideal solution for hair restoration treatments.”
Versatile Applications
The versatility of MicronJet™ extends to numerous applications beyond hair restoration, including skin rejuvenation, treatment of scars, management of axillary hyperhidrosis, alleviation of stretch marks, addressing pigmentation issues, enhancing lip hydration, administering local anesthesia, and more. It efficiently works in conjunction with many substances commonly used in aesthetic practices, such as non-cross-linked hyaluronic acid, skin boosters, polynucleotides, toxins, mesotherapy mixtures, and corticosteroids.
Join the Live Demonstration
The IMCAS World 2026 will provide a prime opportunity for attendees to witness firsthand demonstrations of the MicronJet™ 800. Visitors to the NanoPass booth #K216 can engage with experts and experience the product in action, giving them an opportunity to see how it can revolutionize their practice.
For additional details regarding the MicronJet™ range and its functionalities, please visit
NanoPass's official website.
Conclusion
Overall, the introduction of MicronJet™ 800 signifies a promising progression in the field of intradermal delivery. As aesthetic practices continue to evolve, technologies like those provided by NanoPass are essential for maintaining high standards of patient care while optimizing treatment effectiveness. Looking ahead, the MicronJet™ 800 is positioned to redefine the benchmarks for aesthetic and dermatological applications.